Cognetivity Neurosciences Ltd.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CGN.CN research report →
Companywww.cognetivity.com
Cognetivity Neurosciences Ltd. operates as a healthcare company. It develops an integrated cognitive assessment, a cognitive testing platform for use in medical, commercial, and consumer environments that helps to detect the earliest signs of impairment by testing the performance of large areas of the brain to support the diagnosis of dementia; and offers OptiMind, a wellness app.
- CEO
- Sina Habibi
- IPO
- 2018
- Employees
- 2,500
- HQ
- Vancouver, BC, CA
Price Chart
Valuation
- Market Cap
- $895.89K
- P/E
- -0.13
- P/S
- 19.75
- P/B
- -0.10
- EV/EBITDA
- 0.01
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 45.70%
- Op Margin
- -14085.44%
- Net Margin
- -16386.72%
- ROE
- 95.52%
- ROIC
- 98.71%
Growth & Income
- Revenue
- $45.37K · 0.00%
- Net Income
- $-7,434,000 · 43.37%
- EPS
- $-0.08 · 55.56%
- Op Income
- $-6,390,000
- FCF YoY
- -81.38%
Performance & Tape
- 52W High
- $0.04
- 52W Low
- $0.01
- 50D MA
- $0.01
- 200D MA
- $0.01
- Beta
- -0.42
- Avg Volume
- 0
Get TickerSpark's AI analysis on CGN.CN
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our CGN.CN Coverage
We haven't published any research on CGN.CN yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate CGN.CN Report →